Pharming N.V.(PHAR) - 2024 Q3 - Earnings Call Presentation

Pharming Group N.V. Third quarter 2024 financial results and business update October 24, 2024 NASDAQ: PHAR | EURONEXT Amsterdam: PHARM � Pharming® SPEAKERS Sijmen de Vries, MD Stephen Toor Chief Executive Officer Chief Commercial Officer Anurag Relan, MD Jeroen Wakkerman Chief Medical Officer Chief Financial Officer Forward-looking statements This presentation may contain forward-looking statements. Forward-looking statements are statements of future expectations that are based on management's current expec ...